Reaction Details Report a problem with these data
Target
Urokinase-type plasminogen activator
Ligand
BDBM50144551
Substrate
n/a
Meas. Tech.
ChEBML_210755
IC50
34±n/a nM
Citation
 Sutton, JC; Bolton, SA; Davis, ME; Hartl, KS; Jacobson, B; Mathur, A; Ogletree, ML; Slusarchyk, WA; Zahler, R; Seiler, SM; Bisacchi, GS Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors. Bioorg Med Chem Lett 14:2233-9 (2004) [PubMed]  Article 
Target
Name:
Urokinase-type plasminogen activator
Synonyms:
3.4.21.73 | PLAU | U-plasminogen activator | UROK_HUMAN | Urokinase | Urokinase-type plasminogen activator (uPA) | Urokinase-type plasminogen activator chain B | Urokinase-type plasminogen activator long chain A | Urokinase-type plasminogen activator short chain A | Urokinase-type plasminogen activator/surface receptor | uPA
Type:
Enzyme
Mol. Mass.:
48528.62
Organism:
Homo sapiens (Human)
Description:
P00749
Residue:
431
Sequence:
MRALLARLLLCVLVVSDSKGSNELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQHCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDALQLGLGKHNYCRNPDNRRRPWCYVQVGLKLLVQECMVHDCADGKKPSSPPEELKFQCGQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL
  
Inhibitor
Name:
BDBM50144551
Synonyms:
(2S,3R)-1-(4-tert-Butylcarbamoyl-piperazine-1-carbonyl)-4-oxo-3-piperidin-4-ylmethyl-azetidine-2-carboxylic acid | CHEMBL70155
Type:
Small organic molecule
Emp. Form.:
C20H33N5O5
Mol. Mass.:
423.5065
SMILES:
CC(C)(C)NC(=O)N1CCN(CC1)C(=O)N1[C@@H]([C@@H](CC2CCNCC2)C1=O)C(O)=O
Structure:
Search PDB for entries with ligand similarity: